BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16219965)

  • 21. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
    Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
    Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful use of clopidogrel for cerebrovascular accident in a patient with suspected ticlopidine-induced hepatotoxicity.
    Zeolla MM; Carson JJ
    Ann Pharmacother; 1999 Sep; 33(9):939-41. PubMed ID: 10492495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute hepatitis associated with clopidogrel: a case report and review of the literature.
    Pisapia R; Abdeddaim A; Mariano A; Rianda A; Vincenzi L; Taibi C; Baiocchini A; Del Nonno F; DʼOffizi G
    Am J Ther; 2015; 22(1):e8-e13. PubMed ID: 23846525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current antiplatelet therapies: benefits and limitations.
    Angiolillo DJ; Guzman LA; Bass TA
    Am Heart J; 2008 Aug; 156(2 Suppl):S3-9. PubMed ID: 18657680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.
    Claeys MJ; Van der Planken MG; Bosmans JM; Michiels JJ; Vertessen F; Van Der Goten P; Wuyts FL; Vrints CJ
    Eur Heart J; 2005 Mar; 26(6):567-75. PubMed ID: 15618034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
    Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elective percutaneous coronary intervention using broad-spectrum antiplatelet therapy (eptifibatide, clopidogrel, and aspirin) alone, without scheduled unfractionated heparin or other antithrombin therapy.
    Denardo SJ; Davis KE; Tcheng JE
    Am Heart J; 2005 Jan; 149(1):138-44. PubMed ID: 15660045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged jaundice following percutaneous coronary intervention and ticlopidine therapy.
    Tsui PT; Lai ST; Leung WS; Mok NS; Wu CW; Lau ST; Choi YC
    Hong Kong Med J; 2002 Feb; 8(1):57-9. PubMed ID: 11861996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prior clopidogrel use and outcome of acute coronary syndrome.
    Soiza RL; Leslie SJ
    Int J Cardiol; 2006 Aug; 111(2):313-4. PubMed ID: 16266761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clopidogrel-induced hepatotoxicity].
    Ramos Ramos JC; Sanz Moreno J; Calvo Carrasco L; García Díaz Jde D
    Med Clin (Barc); 2003 Feb; 120(4):156-7. PubMed ID: 12605844
    [No Abstract]   [Full Text] [Related]  

  • 31. [Late-appearing cholestatic icterus after a month of treatment with ticlopidine].
    Placci A; Melandri G; Cecilioni L; Valgimigli M; Bolondi L; Branzi A
    Ital Heart J Suppl; 2001 Nov; 2(11):1240-2. PubMed ID: 11775418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent.
    Satish B; Tressa K; Harish CR
    Crit Pathw Cardiol; 2007 Mar; 6(1):24-5. PubMed ID: 17667883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.
    Cuisset T; Frere C; Quilici J; Gaborit B; Castelli C; Poyet R; Bali L; Morange PE; Alessi MC; Bonnet JL
    Am J Cardiol; 2009 Oct; 104(8):1078-82. PubMed ID: 19801028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemolytic uremic syndrome associated with clopidogrel: a case report.
    Moy B; Wang JC; Raffel GD; Marcoux JP
    Arch Intern Med; 2000 May; 160(9):1370-2. PubMed ID: 10809043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
    Orford JL; Fasseas P; Melby S; Burger K; Steinhubl SR; Holmes DR; Berger PB
    Am Heart J; 2004 Mar; 147(3):463-7. PubMed ID: 14999195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
    Jeong YH; Hwang JY; Kim IS; Park Y; Hwang SJ; Lee SW; Kwak CH; Park SW
    Circ Cardiovasc Interv; 2010 Feb; 3(1):17-26. PubMed ID: 20118150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative evaluation of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Dasbiswas A; Rao MS; Babu PR; Vijayvergiya R; Nayak R; Dani S; Tyagi S; Hiremath S; Patel T; Alexander T; Prakash VS; Singh DP; Yadav MK; Pathak K; Srivastava A
    J Assoc Physicians India; 2013 Feb; 61(2):114-6, 126. PubMed ID: 24471250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?
    Steinhubl S; Berger P
    Am Heart J; 2003 Jun; 145(6):971-8. PubMed ID: 12796751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
    Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
    Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.